Aakaar Medical Technologies (NSE:AAKAAR) Piotroski F-Score: 5 (As of Jul. 16, 2026) — 17% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:AAKAAR Aakaar Medical Technologies Ltd NSE:AAKAAR
20 GF Score
Price ₹70.20
! 3 Warning Signs
View Full Analysis

What is Aakaar Medical Technologies Piotroski F-Score?

Aakaar Medical Technologies NSE:AAKAAR -1.06% 20 Piotroski F-Score is 5 as of Jul. 16, 2026, which is 17% below its 10-year median of 6.00. GuruFocus rates NSE:AAKAAR with a GF Score™ of 20/100. The stock has 3 warning signs investors should review. Among 803 Medical Devices & Instruments companies, Aakaar Medical Technologies ranks better than 65.38% on this metric.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Aakaar Medical Technologies has an F-score of 5 indicating the company's financial situation is typical for a stable company.

The historical rank and industry rank for Aakaar Medical Technologies's Piotroski F-Score or its related term are showing as below:

NSE:AAKAAR' s Piotroski F-Score Range Over the Past 10 Years
Min: 5   Med: 6   Max: 6
Current: 5

During the past 5 years, the highest Piotroski F-Score of Aakaar Medical Technologies was 6. The lowest was 5. And the median was 6.

Aakaar Medical Technologies  (NSE:AAKAAR) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Aakaar Medical Technologies Piotroski F-Score Related Terms


Aakaar Medical Technologies Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Aakaar Medical Technologies's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aakaar Medical Technologies Piotroski F-Score Chart

Aakaar Medical Technologies Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Piotroski F-Score
N/A N/A 6.00 6.00 5.00

Aakaar Medical Technologies Semi-Annual Data
Mar22 Mar23 Mar24 Sep24 Mar25 Sep25 Mar26
Piotroski F-Score Get a 7-Day Free Trial 6.00 0.00 6.00 0.00 5.00

NSE:AAKAAR vs ABT, SYK, MDT: Piotroski F-Score Comparison

For the Medical Devices subindustry, Aakaar Medical Technologies's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Aakaar Medical Technologies Piotroski F-Score vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Aakaar Medical Technologies's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Aakaar Medical Technologies's Piotroski F-Score falls into.


NSE:AAKAAR
20GF Score
Aakaar Medical Technologies Ltd NSE:AAKAAR
Piotroski F-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was ₹66.4 Mil.
Cash Flow from Operations was ₹-83.6 Mil.
Revenue was ₹669.0 Mil.
Gross Profit was ₹386.8 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was (541.597 + 794.166) / 2 = ₹667.8815 Mil.
Total Assets at the begining of this year (Mar25) was ₹541.6 Mil.
Long-Term Debt & Capital Lease Obligation was ₹0.0 Mil.
Total Current Assets was ₹766.1 Mil.
Total Current Liabilities was ₹238.8 Mil.
Net Income was ₹60.3 Mil.

Revenue was ₹615.0 Mil.
Gross Profit was ₹352.5 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was (340.089 + 541.597) / 2 = ₹440.843 Mil.
Total Assets at the begining of last year (Mar24) was ₹340.1 Mil.
Long-Term Debt & Capital Lease Obligation was ₹0.0 Mil.
Total Current Assets was ₹518.4 Mil.
Total Current Liabilities was ₹299.6 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Aakaar Medical Technologies's current Net Income (TTM) was 66.4. ==> Positive ==> Score 1.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Aakaar Medical Technologies's current Cash Flow from Operations (TTM) was -83.6. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=66.376/541.597
=0.12255607

ROA (Last Year)=Net Income/Total Assets (Mar24)
=60.327/340.089
=0.17738592

Aakaar Medical Technologies's return on assets of this year was 0.12255607. Aakaar Medical Technologies's return on assets of last year was 0.17738592. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Aakaar Medical Technologies's current Net Income (TTM) was 66.4. Aakaar Medical Technologies's current Cash Flow from Operations (TTM) was -83.6. ==> -83.6 <= 66.4 ==> CFROA <= ROA ==> Score 0.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=0/667.8815
=0

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=0/440.843
=0

Aakaar Medical Technologies's gearing of this year was 0. Aakaar Medical Technologies's gearing of last year was 0. ==> This year is lower or equal to last year. ==> Score 1.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=766.121/238.83
=3.2078089

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=518.355/299.564
=1.7303648

Aakaar Medical Technologies's current ratio of this year was 3.2078089. Aakaar Medical Technologies's current ratio of last year was 1.7303648. ==> This year's current ratio is higher. ==> Score 1.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Aakaar Medical Technologies's number of shares in issue this year was 13.289. Aakaar Medical Technologies's number of shares in issue last year was 14.173. ==> There is smaller number of shares in issue this year, or the same. ==> Score 1.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=386.798/669.038
=0.57814055

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=352.46/614.957
=0.57314576

Aakaar Medical Technologies's gross margin of this year was 0.57814055. Aakaar Medical Technologies's gross margin of last year was 0.57314576. ==> This year's gross margin is higher. ==> Score 1.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=669.038/541.597
=1.23530596

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=614.957/340.089
=1.80822373

Aakaar Medical Technologies's asset turnover of this year was 1.23530596. Aakaar Medical Technologies's asset turnover of last year was 1.80822373. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=1+0+0+0+1+1+1+1+0
=5

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Aakaar Medical Technologies has an F-score of 5 indicating the company's financial situation is typical for a stable company.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 5 mean?
Aakaar Medical Technologies (NSE:AAKAAR) has a Piotroski F-Score of 5 as of Jul. 16, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Aakaar Medical Technologies and its competitors. This is 17% below median its historical median of 6.00. Over the past decade, Aakaar Medical Technologies' Piotroski F-Score has ranged from 5.00 to 6.00. According to the industry distribution chart, Aakaar Medical Technologies ranks #278 out of 803 companies in the Medical Devices & Instruments industry, placing it in the top 34.6%.
Is Aakaar Medical Technologies' Piotroski F-Score too high?
Aakaar Medical Technologies' current Piotroski F-Score of 5 is 17% below median its 10-year median of 6.00. Over the past 10 years, this metric has ranged from a low of 5.00 to a high of 6.00. The Medical Devices & Instruments industry median Piotroski F-Score is 5.00. Aakaar Medical Technologies' value of 5 is 0% at this industry median. Based on the distribution chart, Aakaar Medical Technologies ranks #278 out of 803 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Aakaar Medical Technologies has a GF Score™ of 20/100, reflecting its overall financial health beyond just this single metric.
How does Aakaar Medical Technologies' Piotroski F-Score compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Aakaar Medical Technologies ranks #278 out of 803 companies for Piotroski F-Score. This puts Aakaar Medical Technologies in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Aakaar Medical Technologies' value of 5 is 0% at this benchmark. Historically, Aakaar Medical Technologies' own Piotroski F-Score has ranged from 5.00 to 6.00 over the past decade. While the company's 10-year median is 6.00 vs. the industry median of 5.00, Aakaar Medical Technologies has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Devices & Instruments company?
The median Piotroski F-Score among Medical Devices & Instruments companies is 5.00, based on 803 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aakaar Medical Technologies's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Aakaar Medical Technologies and its competitors. For the Medical Devices & Instruments industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aakaar Medical Technologies's current Piotroski F-Score is 5, which is 17% below median its own 10-year median of 6.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aakaar Medical Technologies stock overvalued right now?
Aakaar Medical Technologies (NSE:AAKAAR) has a current Piotroski F-Score of 5. The current Piotroski F-Score is 5, which is 17% below median its 10-year median of 6.00 and 0% at the Medical Devices & Instruments industry median of 5.00. Aakaar Medical Technologies' overall GF Score™ is 20/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Aakaar Medical Technologies (NSE:AAKAAR), the current Piotroski F-Score is 5 as of Jul. 16, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aakaar Medical Technologies Business Description

Address Telli Galli Cross Road, A - 801, Heritage Plaza, Andheri East, Mumbai, MH, IND, 400 069
Aakaar Medical Technologies Ltd is a medical aesthetic company dealing in a wide range of aesthetics & specialized cosmetic products & devices. Its product range includes both Own brands (domestically manufactured products & internationally manufactured devices) and Imported Brands (distribution of imported brands) from countries such as Korea, Spain, Italy, and Austria. It has established a distinctive presence in the medical aesthetic market by exclusively focusing on business-to-business(B2B) channels for product distribution and sales. The company supply its products & devices to dermatologists, plastic surgeons, aesthetic physicians who then sell these products to their end consumers as well as use certain device consumables as part of their treatments.
20GF Score

Get the complete analysis for NSE:AAKAAR

Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹70.20
Price